MIS18A上调促进细胞活力,迁移和瘤免疫逃避在肺腺癌
Yongjie Zhu1, Zihao Li2, Zuotao Wu1
1Department of Cardio-Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Oncology letters
|June 24, 2024
概括
在肺腺癌 (LUAD) 中增加MIS18基因蛋白A (MIS18A) 表达与预后不佳相关,并影响瘤微环境. 抑制MIS18A可能为LUAD提供治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肺腺癌 (LUAD) 是癌症死亡的主要原因之一,预后不佳.
- 在LUAD病变发生过程中,MIS18动态蛋白A (MIS18A) 的特定作用尚不完全理解.
研究的目的:
- 研究MIS18A对LUAD进展,预后和免疫微环境的影响.
- 评估MIS18A作为潜在的生物标志物和LUAD的治疗标.
主要方法:
- 从公开的LUAD数据集中分析基因组和临床数据.
- 使用逆转录定量聚合酶链反应 (RT-qPCR) 验证MIS18A表达.
- 在体外实验中使用小干扰RNA (siRNA) 来降低LUAD细胞中MIS18A的调节.
主要成果:
- 较高的MIS18A表达与晚期临床特征和LUAD的更差预后有关.
- 在LUAD微环境中,MIS18A影响细胞循环调节和与免疫相关的途径.
- 低调 MIS18A 减少了 LUAD 细胞在体外的增殖和迁移.
- MIS18A会影响LUAD对免疫治疗的反应和药物敏感性.
结论:
- MIS18A与激进的LUAD表型和患者的不良结果有关.
- MIS18A在调节瘤免疫微环境和细胞行为方面发挥作用.
- MIS18A具有作为肺腺癌的预后生物标志物和治疗点的潜力.
更多相关视频
11:00Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
981
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
